Preservación de fertilidad en endometriosis: estado actual de conocimiento y papel del sistema público de salud

Laura de la Fuente , Sofía Ortega , Ana Monzó , Berta Martín , Maria José Iñarra , Corazón Hernández , Belén Castells , Bárbara Romero , Jose Luis Muñoz , Ana Belen Casas
{"title":"Preservación de fertilidad en endometriosis: estado actual de conocimiento y papel del sistema público de salud","authors":"Laura de la Fuente ,&nbsp;Sofía Ortega ,&nbsp;Ana Monzó ,&nbsp;Berta Martín ,&nbsp;Maria José Iñarra ,&nbsp;Corazón Hernández ,&nbsp;Belén Castells ,&nbsp;Bárbara Romero ,&nbsp;Jose Luis Muñoz ,&nbsp;Ana Belen Casas","doi":"10.1016/j.medre.2016.06.001","DOIUrl":null,"url":null,"abstract":"<div><p>Endometriosis is a prevalent and polymorphic disease in which fertility may be impaired. Some patients may have an ovarian reverse loss, compromising their reproductive future, even with assisted reproduction techniques.</p><p>Early diagnosis and accurate follow-up are essential to avoid endometriosis consequences, not only on fertility, but also on quality of life. Professionals from different fields need an adequate training and collaboration with other specialists. For integrated fertility preservation, measures for preventing recurrence (mainly oral contraception), individualised surgery indications, ovarian tissue conservative surgical techniques and, in selected cases, oocyte vitrification should be considered.</p><p>Although patients must be informed of the benefits of pregnancy at a young age, this is often a non-realistic option. Oocyte vitrification is an effective alternative to postpone maternity, but its efficacy is related to the age of the woman and to the quantity and quality of the oocytes obtained. Publications related to preservation in endometriosis are scarce, and extrapolating data from other kinds of patients, although inexact, is the only available reference.</p><p>Oocyte vitrification in public health systems should have some cost-benefit conditions. It should be offered in cases with a real risk of ovarian reserve loss, but when there are adequate conditions to achieve an ovarian stimulation response to be able to obtain a sufficient number of oocytes. Patients with endometriosis will be candidates for vitrification if they fulfil two conditions: 1) bilateral endometrioma of more than 4<!--> <!-->cm, or post-surgical recurrence of endometriosis, and 2)- age ≤<!--> <!-->35 years and ovarian reserve markers excluding low ovarian reserve (AMH<!--> <!-->&gt;<!--> <!-->1<!--> <!-->ng/ml; antral follicle count<!--> <!-->&gt;<!--> <!-->5; FSH<!--> <!-->&gt;<!--> <!-->10<!--> <!-->mg/ml). As 10 vitrified oocytes should be considered a sufficient number, a maximum of 2 cycles will be offered to reach this number. Follow-up of these cases will allow an evaluation of the efficacy and efficiency of this policy to be made in the future.</p></div>","PeriodicalId":100911,"journal":{"name":"Medicina Reproductiva y Embriología Clínica","volume":"3 3","pages":"Pages 119-127"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medre.2016.06.001","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Reproductiva y Embriología Clínica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2340932016300068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Endometriosis is a prevalent and polymorphic disease in which fertility may be impaired. Some patients may have an ovarian reverse loss, compromising their reproductive future, even with assisted reproduction techniques.

Early diagnosis and accurate follow-up are essential to avoid endometriosis consequences, not only on fertility, but also on quality of life. Professionals from different fields need an adequate training and collaboration with other specialists. For integrated fertility preservation, measures for preventing recurrence (mainly oral contraception), individualised surgery indications, ovarian tissue conservative surgical techniques and, in selected cases, oocyte vitrification should be considered.

Although patients must be informed of the benefits of pregnancy at a young age, this is often a non-realistic option. Oocyte vitrification is an effective alternative to postpone maternity, but its efficacy is related to the age of the woman and to the quantity and quality of the oocytes obtained. Publications related to preservation in endometriosis are scarce, and extrapolating data from other kinds of patients, although inexact, is the only available reference.

Oocyte vitrification in public health systems should have some cost-benefit conditions. It should be offered in cases with a real risk of ovarian reserve loss, but when there are adequate conditions to achieve an ovarian stimulation response to be able to obtain a sufficient number of oocytes. Patients with endometriosis will be candidates for vitrification if they fulfil two conditions: 1) bilateral endometrioma of more than 4 cm, or post-surgical recurrence of endometriosis, and 2)- age ≤ 35 years and ovarian reserve markers excluding low ovarian reserve (AMH > 1 ng/ml; antral follicle count > 5; FSH > 10 mg/ml). As 10 vitrified oocytes should be considered a sufficient number, a maximum of 2 cycles will be offered to reach this number. Follow-up of these cases will allow an evaluation of the efficacy and efficiency of this policy to be made in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫内膜异位症的生育能力保存:公共卫生系统的知识现状和作用
子宫内膜异位症是一种普遍的多形性疾病,其生育能力可能受损。一些患者可能有卵巢逆转录功能丧失,影响他们的生殖未来,即使有辅助生殖技术。早期诊断和准确的随访是必不可少的,以避免子宫内膜异位症的后果,不仅对生育能力,而且对生活质量。来自不同领域的专业人员需要充分的培训和与其他专家的合作。对于综合保存生育能力,应考虑预防复发的措施(主要是口服避孕药),个体化手术指征,卵巢组织保守手术技术,并在选定的病例中考虑卵母细胞玻璃化。虽然必须告知患者在年轻时怀孕的好处,但这通常是一个不现实的选择。卵母细胞玻璃化是推迟生育的一种有效的替代方法,但其效果与妇女的年龄和获得的卵母细胞的数量和质量有关。与子宫内膜异位症保存相关的出版物很少,从其他类型的患者中推断数据,虽然不准确,但是唯一可用的参考。公共卫生系统中的卵母细胞玻璃化应具有一定的成本效益条件。它应该在卵巢储备丧失风险的情况下提供,但当有足够的条件实现卵巢刺激反应,能够获得足够数量的卵母细胞时。子宫内膜异位症患者如果满足以下两个条件,将成为玻璃化手术的候选人:1)双侧子宫内膜异位症大于4厘米,或术后子宫内膜异位症复发;2)年龄≤35岁,卵巢储备指标不包括低卵巢储备(AMH >1 ng / ml;窦卵泡计数;5;FSH在10毫克/毫升)。由于10个玻璃化卵母细胞应该被认为是足够的数量,因此最多需要2个周期才能达到这个数量。这些案件的后续行动将使今后能够对这项政策的效力和效率作出评价。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Extended embryo culture up to 14 days Impact of administration route on serum progesterone levels in women undergoing artificial endometrial preparation Efecto de la abstinencia sexual masculina en los resultados reproductivos Sperm DNA fragmentation and microfluidics: A new era in human sperm selection Aplicación de la inteligencia artificial en el laboratorio de reproducción asistida. Trabajo de revisión
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1